Leonard Ariff Bin Abdul Shatar

Group Managing Director, Executive Director


57 years




  • Bachelor of Laws (LLB), Monash University, Melbourne, Australia
  • Bachelor of Economics, Monash University, Melbourne, Australia

Position on the Board

Group Managing Director, Executive Director

Working Experience and Occupation

Leonard Ariff has more than 30 years’ experience in the legal, chemical and pharmaceutical industries. Upon graduating in 1988, he was a pupil in a legal firm in Kuala Lumpur and also worked in the Petronas Group of Companies before joining Chemical Company of Malaysia Berhad (“CCM Berhad”) Group in 1990, where his main responsibilities were in business development and business management at CCM Chemicals Sdn. Bhd. In 2000, he assumed the position of Managing Director of Usaha Pharma (M) Sdn. Bhd., CCM Berhad’s Pharmaceuticals retail arm. He joined ICI Paints Malaysia Sdn. Bhd. in 2003 as its General Manager and was appointed Managing Director in 2005, before returning to the CCM Berhad Group in 2008 as Chief Executive Officer of CCM Duopharma Biotech Berhad. He was made a Director of CCM Berhad’s Chemicals Division from October 2014 until December 2015. On 9 January 2015, he was also appointed Group Managing Director of CCM Berhad, and served in that position until 28 December 2017, when he was appointed to the Board and redesignated as Group Managing Director of Duopharma Biotech Berhad.

Leonard Ariff is also a Director of Monash University Malaysia Sdn Bhd as well as sitting on the Advisory Committee for the Business School at Monash University Malaysia. He has been appointed to participate in the CEO @ Faculty programme by the Ministry of Education, assigned to University Kebangsaan Malaysia (UKM). On 31 March 2021, he was appointed as a trustee for the National Institutes of Biotechnology Malaysia. Leonard Ariff was recently appointed as a committee of the Action Group for Entrepreneurship (AGE Council) at University Malaysia Kelantan (UMK). He was President of the Malaysian Organisation of Pharmaceutical Industries from 2009 to 2014.

He has completed the Qualified Risk Director (QRD) programme and is a member of the Institute of Enterprise Risk Practitioners (IERP). Leonard Ariff is also a member of the Institute of Corporate Directors Malaysia (ICDM). He is the Chairman of Duopharma Biotech’s Group Management Committee.

Directorships of Other Public Companies

  • PanGen Biotech Inc. (Korea)
  • SCM Lifescience Inc. (Korea)